Age- and gender-specific modulation of serum osteopontin and interferon-alpha by osteopontin genotype in systemic lupus erythematosus
- PMID: 19339987
- PMCID: PMC2762275
- DOI: 10.1038/gene.2009.15
Age- and gender-specific modulation of serum osteopontin and interferon-alpha by osteopontin genotype in systemic lupus erythematosus
Abstract
Osteopontin (OPN) is a multifunctional cytokine involved in long bone remodeling and immune system signaling. Additionally, OPN is critical for interferon-alpha (IFN-alpha) production in murine plasmacytoid dendritic cells. We have previously shown that IFN-alpha is a heritable risk factor for systemic lupus erythematosus (SLE). Genetic variants of OPN have been associated with SLE susceptibility, and one study suggests that this association is particular to men. In this study, the 3' UTR SLE-risk variant of OPN (rs9138C) was associated with higher serum OPN and IFN-alpha in men (P=0.0062 and P=0.0087, respectively). In women, the association between rs9138 C and higher serum OPN and IFN-alpha was restricted to younger subjects, and risk allele carriers showed a strong age-related genetic effect of rs9138 genotype on both serum OPN and IFN-alpha (P<0.0001). In African-American subjects, the 5' region single nucleotide polymorphisms, rs11730582 and rs28357094, were associated with anti-RNP antibodies (odds ratio (OR)=2.9, P=0.0038 and OR=3.9, P=0.021, respectively). Thus, we demonstrate two distinct genetic influences of OPN on serum protein traits in SLE patients, which correspond to previously reported SLE-risk variants. This study provides a biologic relevance for OPN variants at the protein level, and suggests an influence of this gene on the IFN-alpha pathway in SLE.
Figures





Similar articles
-
Osteopontin alleles are associated with clinical characteristics in systemic lupus erythematosus.J Biomed Biotechnol. 2011;2011:802581. doi: 10.1155/2011/802581. Epub 2011 Oct 26. J Biomed Biotechnol. 2011. PMID: 22131818 Free PMC article.
-
Osteopontin and interleukin-17A genes polymorphisms in Egyptian systemic lupus erythematosus patients: A relation to disease activity and severity.Gene. 2019 Jun 20;702:107-113. doi: 10.1016/j.gene.2019.02.100. Epub 2019 Mar 19. Gene. 2019. PMID: 30898714
-
Correlation between circulating osteopontin level in systemic lupus erythematosus and disease activity and associations between osteopontin polymorphisms and disease susceptibility: A meta-analysis.Lupus. 2017 Feb;26(2):132-138. doi: 10.1177/0961203316655214. Epub 2016 Jul 11. Lupus. 2017. PMID: 27307447 Review.
-
Osteopontin and Disease Activity in Patients with Recent-onset Systemic Lupus Erythematosus: Results from the SLICC Inception Cohort.J Rheumatol. 2019 May;46(5):492-500. doi: 10.3899/jrheum.180713. Epub 2019 Jan 15. J Rheumatol. 2019. PMID: 30647177 Free PMC article.
-
Role of osteopontin in systemic lupus erythematosus.Arch Immunol Ther Exp (Warsz). 2014 Dec;62(6):475-82. doi: 10.1007/s00005-014-0294-x. Epub 2014 Jun 11. Arch Immunol Ther Exp (Warsz). 2014. PMID: 24917428 Free PMC article. Review.
Cited by
-
The role of osteopontin (OPN/SPP1) haplotypes in the susceptibility to Crohn's disease.PLoS One. 2011;6(12):e29309. doi: 10.1371/journal.pone.0029309. Epub 2011 Dec 29. PLoS One. 2011. PMID: 22242114 Free PMC article.
-
Single-cell expression quantitative trait loci (eQTL) analysis of SLE-risk loci in lupus patient monocytes.Arthritis Res Ther. 2021 Nov 30;23(1):290. doi: 10.1186/s13075-021-02660-2. Arthritis Res Ther. 2021. PMID: 34847931 Free PMC article.
-
Burden of systemic lupus erythematosus in Taiwan: a population-based survey.Rheumatol Int. 2013 Jul;33(7):1805-11. doi: 10.1007/s00296-012-2643-6. Epub 2013 Jan 12. Rheumatol Int. 2013. PMID: 23314932
-
Monogenic forms of systemic lupus erythematosus: new insights into SLE pathogenesis.Pediatr Rheumatol Online J. 2012 Aug 10;10(1):21. doi: 10.1186/1546-0096-10-21. Pediatr Rheumatol Online J. 2012. PMID: 22883345 Free PMC article.
-
Genetics of the type I interferon pathway in systemic lupus erythematosus.Int J Clin Rheumtol. 2013 Dec 1;8(6):10.2217/ijr.13.58. doi: 10.2217/ijr.13.58. Int J Clin Rheumtol. 2013. PMID: 24416080 Free PMC article.
References
-
- Harley JB, Kelly JA, Kaufman KM. Unraveling the genetics of systemic lupus erythematosus. Springer Semin Immunopathol. 2006;28:119–130. - PubMed
-
- Blanco P, Palucka AK, Gill M, Pascual V, Banchereau J. Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science. 2001;294:1540–1543. - PubMed
-
- Hooks JJ, Moutsopoulos HM, Geis SA, Stahl NI, Decker JL, Notkins AL. Immune interferon in the circulation of patients with autoimmune disease. N Engl J Med. 1979;301:5–8. - PubMed
-
- Kirou KA, Lee C, George S, Louca K, Peterson MG, Crow MK. Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease. Arthritis Rheum. 2005;52:1491–1503. - PubMed
-
- Ronnblom LE, Alm GV, Oberg KE. Possible induction of systemic lupus erythematosus by interferon-alpha treatment in a patient with a malignant carcinoid tumour. J Intern Med. 1990;227:207–210. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials